Pure insulin nanoparticle agglomerates for pulmonary delivery
Diabetes is a set of diseases characterized by defects in insulin utilization, either through autoimmune destruction of insulin-producing cells (Type I) or insulin resistance (Type II). Treatment options can include regular injections of insulin, which can be painful and inconvenient, often leading...
Description complète
Détails bibliographiques
| Publié dans: | Langmuir : the ACS journal of surfaces and colloids. - 1985. - 24(2008), 23 vom: 02. Dez., Seite 13614-20
|
|---|
| Auteur principal: |
Bailey, Mark M
(Auteur) |
|---|
| Autres auteurs: |
Gorman, Eric M,
Munson, Eric J,
Berkland, Cory |
|---|
| Format: | Article en ligne
|
|---|
| Langue: | English |
|---|
| Publié: |
2008
|
|---|
| Accès à la collection: | Langmuir : the ACS journal of surfaces and colloids
|
|---|
| Sujets: | Journal Article
Research Support, N.I.H., Extramural
Research Support, Non-U.S. Gov't
Drug Carriers
Insulin
Powders |
|---|